268 related articles for article (PubMed ID: 33322922)
1. Hypersensitivity to calcitonin gene-related peptide in chronic migraine.
Iljazi A; Ashina H; Zhuang ZA; Lopez Lopez C; Snellman J; Ashina M; Schytz HW
Cephalalgia; 2021 May; 41(6):701-710. PubMed ID: 33322922
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine.
Guo S; Christensen AF; Liu ML; Janjooa BN; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):114-124. PubMed ID: 26994300
[TBL] [Abstract][Full Text] [Related]
3. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
4. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
5. Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil.
Younis S; Christensen CE; Toft NM; Søborg T; Amin FM; Hougaard A; Ashina M
Cephalalgia; 2019 Dec; 39(14):1776-1788. PubMed ID: 31684759
[TBL] [Abstract][Full Text] [Related]
6. An exploratory analysis of clinical and sociodemographic factors in CGRP-induced migraine attacks: A REFORM study.
Al-Khazali HM; Ashina H; Christensen RH; Wiggers A; Rose K; Iljazi A; Schytz HW; Amin FM; Ashina M
Cephalalgia; 2023 Oct; 43(10):3331024231206375. PubMed ID: 37815254
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Meßlinger K
Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
[TBL] [Abstract][Full Text] [Related]
9. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
10. Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients.
Ghanizada H; Al-Karagholi MA; Walker CS; Arngrim N; Rees T; Petersen J; Siow A; Mørch-Rasmussen M; Tan S; O'Carroll SJ; Harris P; Skovgaard LT; Jørgensen NR; Brimble M; Waite JS; Rea BJ; Sowers LP; Russo AF; Hay DL; Ashina M
Ann Neurol; 2021 Jun; 89(6):1157-1171. PubMed ID: 33772845
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide does not cause migraine attacks in patients with familial hemiplegic migraine.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Headache; 2011 Apr; 51(4):544-53. PubMed ID: 21457239
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
Hansen JM; Thomsen LL; Olesen J; Ashina M
Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
[TBL] [Abstract][Full Text] [Related]
14. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
15. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.
Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M
J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109
[TBL] [Abstract][Full Text] [Related]
16. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache.
Ashina H; Iljazi A; Al-Khazali HM; Christensen CE; Amin FM; Ashina M; Schytz HW
Ann Neurol; 2020 Dec; 88(6):1220-1228. PubMed ID: 32959458
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
[TBL] [Abstract][Full Text] [Related]
19. Enhanced post-traumatic headache-like behaviors and diminished contribution of peripheral CGRP in female rats following a mild closed head injury.
Bree D; Mackenzie K; Stratton J; Levy D
Cephalalgia; 2020 Jun; 40(7):748-760. PubMed ID: 32077327
[TBL] [Abstract][Full Text] [Related]
20. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
